Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Long‐term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia

HemaSphere(2025)10.1002/hem3.70067Source: DataRank Database

Long‐term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia is a research paper published in HemaSphere (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: goldTopics (17)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Yue Ren ORCID,Svitlana Tyekucheva ORCID,Jon Arnason ORCID,Adam Boruchov,Caron A. Jacobson ORCID

Live enrichment

PubMed:39816532 PMC:PMC11733307 OpenAlex:https://openalex.org/W4406404500

NCI NIH HHS

Grant: R01 CA266298

NCI NIH HHS

Grant: P01 CA206978

NCI NIH HHS

Grant: T32 CA009172

National Institutes of Health

Grant: 5R01CA266298-03

Optimizing novel agent combination therapy for previously untreated, high risk chronic lymphocytic leukemia

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hem3.70067

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hem3.70067

journalhttps://doi.org/10.1002/hem3.70067

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39816532

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11733307

Fields of Study

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentImmunodeficiency and Autoimmune Disorders03 medical and health sciences0302 clinical medicine

Keywords

IbrutinibChronic lymphocytic leukemiaRefractory (planetary science)MedicineOncologyInternal medicineLeukemiaMaterials scienceMetallurgyLetterDiseases of the blood and blood-forming organsRC633-647.5

Sustainable Development Goals

SDG 0: Zero hunger